Ignite Creation Date:
2024-05-06 @ 5:49 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05441514
Status:
RECRUITING
Last Update Posted:
2023-12-18
First Post:
2022-06-28
Brief Title:
Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Organization:
City of Hope Medical Center